Less Ads, More Data, More Tools Register for FREE

Pin to quick picksYourgene Regulatory News (YGEN)

Share Price Information for Yourgene (YGEN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 15.50
Bid: 15.00
Ask: 16.00
Change: 1.00 (6.90%)
Spread: 1.00 (6.67%)
Open: 14.50
High: 15.50
Low: 14.50
Yest. Close: 14.50
YGEN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

RNS Alerts are a premium feature

Login to your account

myTerminal is a premium feature

Login to your account

Don't have an account? Click here to register.

Yourgene Health PLC - Notice of Results

Thu, 27th Jun 2019 07:00

RNS Number : 5702D
Yourgene Health PLC
27 June 2019

 Yourgene Health plc

("Yourgene Health")


Notice of Results


Manchester, UK - 27 June 2019: Yourgene Health (AIM: YGEN), the international molecular diagnostics group which commercialises genetic products and services, will announce results for the year ended 31 March 2019 on Wednesday 10 July 2019.



For more information, please contact:



Yourgene Health plc

Lyn Rees, Chief Executive Officer

Barry Hextall, Chief Financial Officer

Joanne Cross, Director of Marketing



Tel: +44 (0)161 667 1053



Cairn Financial Advisers LLP (Nomad)

Liam Murray / James Caithie / Ludovico Lazzaretti


Tel: +44 (0)20 7213 0880

Stifel Nicolaus Europe Limited (Corporate Broker)

Nicholas Moore / Matthew Blawat / Ben Maddison


Tel: +44 (0)20 7710 7600

Vigo Communications (PR)

Ben Simons / Fiona Henson / Antonia Pollock


Tel: +44 (0)20 7390 0238




About Yourgene Health

Yourgene Health is an international molecular diagnostics group which develops and commercialises genetic products and services. The group works in partnership with global leaders in DNA technology to advance diagnostic science. 


Yourgene develops and commercialises simple and accurate molecular diagnostic solutions, primarily for reproductive health. The Group's products include non-invasive prenatal tests (NIPT) for Down's Syndrome and other genetic disorders, Cystic Fibrosis screening tests, invasive rapid aneuploidy tests, male infertility tests and genetic disease tests. Yourgene's commercial footprint is already established in the UK, Europe, the Middle East, Africa and Asia.


Our product development, research service and commercial capabilities extend across the lifecycle of genetic test development including regulatory submissions. Through our technical expertise and partnerships, Yourgene Health is also extending its genetic testing offering into oncology.


Yourgene Health is headquartered in Manchester, UK with offices in Taipei and Singapore, and is listed on the London Stock Exchange's AIM market under the ticker "YGEN". For more information visit www.yourgene-health.com and follow us on twitter @Yourgene_Health.


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
Date   Source Headline
27th Mar 20203:00 pmRNSIssue of Share Options
25th Mar 20207:00 amRNSContract manufacturing agreement for COVID-19 test
16th Mar 20204:41 pmRNSSecond Price Monitoring Extn
16th Mar 20204:36 pmRNSPrice Monitoring Extension
13th Mar 202011:51 amRNSHolding(s) in Company

Login to your account

Don't have an account? Click here to register.